| 11/16/2026 8:37 PM | Tevogen Bio (1860871) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 11/04/2026 3:38 PM | Saadi Ryan H. (2011728) Filed by Tevogen Bio (1860871) Subject | Form SCHEDULE 13D/A | |
| 11/04/2026 10:50 AM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/30/2026 3:40 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/16/2026 6:54 PM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2026 6:54 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2026 7:04 PM | Desai Kirti (2011765) Filed by Tevogen Bio (1860871) Subject | Form SCHEDULE 13D/A | |
| 09/16/2026 7:07 PM | Saadi Ryan H. (2011728) Filed by Tevogen Bio (1860871) Subject | Form SCHEDULE 13D/A | |
| 09/16/2026 4:12 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/15/2026 7:08 PM | Goh Keow Lin (2011759) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 7:04 PM | Patton Curtis L. (2011753) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TVGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tevogen and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/15/2026 7:04 PM | Feike Jeffrey L. (2011766) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 7:05 PM | Sordillo Victor J. (2011733) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 7:05 PM | PODLOGAR SUSAN M (1709959) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2026 8:19 AM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/26/2026 2:10 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/24/2026 4:30 PM | Tevogen Bio (1860871) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 08/14/2026 4:16 PM | Tevogen Bio (1860871) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/03/2026 8:20 AM | Tevogen Bio (1860871) Filer | Form DEF 14A | |
| 07/30/2026 7:31 AM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/23/2026 4:29 PM | Tevogen Bio (1860871) Filer | Form PRE 14A | |
| 07/14/2026 8:56 PM | Saadi Ryan H. (2011728) Filed by Tevogen Bio (1860871) Subject | Form SCHEDULE 13D/A | |
| 07/10/2026 4:30 PM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:30 PM | Feike Jeffrey L. (2011766) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:30 PM | Goh Keow Lin (2011759) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:31 PM | Patton Curtis L. (2011753) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:31 PM | PODLOGAR SUSAN M (1709959) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:31 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:31 PM | Sordillo Victor J. (2011733) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:17 PM | Tevogen Bio (1860871) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 06/26/2026 8:18 AM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 06/25/2026 11:15 PM | Tevogen Bio (1860871) Filer | Form EFFECT | |
| 06/12/2026 3:59 PM | Tevogen Bio (1860871) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 05/15/2026 4:01 PM | Tevogen Bio (1860871) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/30/2026 4:00 PM | Tevogen Bio (1860871) Filer | Form 10-K/A | |
| 04/22/2026 4:15 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/31/2026 4:16 PM | Tevogen Bio (1860871) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/25/2026 4:04 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/25/2026 4:10 PM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 03/17/2026 3:29 PM | Flomenberg Neal (2011757) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 8:08 AM | Tevogen Bio (1860871) Filer | Form 424B3 | |
Don’t delete this, read it today (Ad) Porter Stansberry has spent more than 30 years studying the economy and financial markets, and says he has never felt pressure like this. He believes the foundations beneath our way of life have cracked.
One Nobel Prize winner has warned that the force behind it threatens to divide America. Stansberry points to rising living costs, deepening division and building anger as signs.
His documentary, The Final Displacement, names the force and outlines what he believes you can do about it now. Watch Porter Stansberry's documentary The Final Displacement and see what he says you can do. |
| 03/04/2026 8:04 AM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 8:36 AM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 02/06/2026 2:09 PM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/30/2026 2:37 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/26/2026 4:29 PM | Tevogen Bio (1860871) Filer | Form DEF 14A | |
| 01/16/2026 4:29 PM | Tevogen Bio (1860871) Filer | Form PRE 14A | |
| 12/30/2025 9:12 AM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/22/2025 4:43 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 7:47 PM | Saadi Ryan H. (2011728) Filed by Tevogen Bio (1860871) Subject | Form SCHEDULE 13D/A | |
| 12/15/2025 4:31 PM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 5:51 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |